PortfoliosLab logoPortfoliosLab logo
WST vs. AMCR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

WST vs. AMCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in West Pharmaceutical Services, Inc. (WST) and Amcor plc (AMCR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WST achieves a 16.41% return, which is significantly higher than AMCR's -6.58% return.


WST

1D
1.67%
1M
-1.89%
YTD
16.41%
6M
19.03%
1Y
42.78%
3Y*
-2.54%
5Y*
-0.73%
10Y*
15.79%

AMCR

1D
-0.81%
1M
-3.71%
YTD
-6.58%
6M
-5.56%
1Y
-11.82%
3Y*
-3.84%
5Y*
-4.35%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WST vs. AMCR - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
WST
West Pharmaceutical Services, Inc.
16.41%-15.73%-6.75%49.97%-49.70%65.88%89.05%24.85%
AMCR
Amcor plc
-6.58%-6.17%2.61%-14.97%3.20%6.16%13.41%-0.71%

Correlation

The correlation between WST and AMCR is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jun 12, 2019

0.33

Fundamentals

Market Cap

WST:

$23.15B

AMCR:

$17.54B

EPS

WST:

$7.47

AMCR:

$1.59

PE Ratio

WST:

42.80

AMCR:

23.84

PS Ratio

WST:

7.21

AMCR:

0.73

PB Ratio

WST:

7.74

AMCR:

0.47

Total Revenue (TTM)

WST:

$3.22B

AMCR:

$22.19B

Gross Profit (TTM)

WST:

$1.17B

AMCR:

$4.10B

EBITDA (TTM)

WST:

$799.00M

AMCR:

$2.58B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WST vs. AMCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WST
WST Risk / Return Rank: 7373
Overall Rank
WST Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
WST Sortino Ratio Rank: 7777
Sortino Ratio Rank
WST Omega Ratio Rank: 7474
Omega Ratio Rank
WST Calmar Ratio Rank: 7373
Calmar Ratio Rank
WST Martin Ratio Rank: 7070
Martin Ratio Rank

AMCR
AMCR Risk / Return Rank: 2525
Overall Rank
AMCR Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
AMCR Sortino Ratio Rank: 2424
Sortino Ratio Rank
AMCR Omega Ratio Rank: 2424
Omega Ratio Rank
AMCR Calmar Ratio Rank: 2727
Calmar Ratio Rank
AMCR Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WST vs. AMCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Amcor plc (AMCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WSTAMCRDifference
Sharpe ratioReturn per unit of total volatility

+1.43

Sortino ratioReturn per unit of downside risk

+2.38

Omega ratioGain probability vs. loss probability

1.24

0.96

+0.29

Calmar ratioReturn relative to maximum drawdown

1.74

-0.45

+2.19

Martin ratioReturn relative to average drawdown

3.48

-0.81

+4.29

WST vs. AMCR - Sharpe Ratio Comparison

The current WST Sharpe Ratio is 1.05, which is higher than the AMCR Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of WST and AMCR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WSTAMCRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.05

-0.38

+1.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.02

-0.17

+0.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

-0.03

+0.42

Drawdowns

WST vs. AMCR - Drawdown Comparison

The maximum WST drawdown since its inception was -59.29%, which is greater than AMCR's maximum drawdown of -47.21%. Use the drawdown chart below to compare losses from any high point for WST and AMCR.


Loading charts...

Drawdown Indicators


WSTAMCRDifference

Max Drawdown

Largest peak-to-trough decline

-59.29%

-47.21%

-12.08%

Max Drawdown (1Y)

Largest decline over 1 year

-24.70%

-26.51%

+1.81%

Max Drawdown (3Y)

Largest decline over 3 years

-53.79%

-29.92%

-23.87%

Max Drawdown (5Y)

Largest decline over 5 years

-59.29%

-34.24%

-25.05%

Max Drawdown (10Y)

Largest decline over 10 years

-59.29%

Current Drawdown

Current decline from peak

-31.34%

-31.09%

-0.25%

Average Drawdown

Average peak-to-trough decline

-16.88%

-14.54%

-2.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.32%

14.67%

-2.35%

Volatility

WST vs. AMCR - Volatility Comparison

The current volatility for West Pharmaceutical Services, Inc. (WST) is 7.76%, while Amcor plc (AMCR) has a volatility of 9.21%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than AMCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WSTAMCRDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.76%

9.21%

-1.45%

Volatility (6M)

Calculated over the trailing 6-month period

25.25%

25.29%

-0.04%

Volatility (1Y)

Calculated over the trailing 1-year period

41.20%

31.26%

+9.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.57%

25.00%

+15.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.63%

29.22%

+5.41%

Dividends

WST vs. AMCR - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.27%, less than AMCR's 6.84% yield.


PositionTTM20252024202320222021202020192018201720162015
AMCR
Amcor plc
6.84%6.15%5.34%5.11%4.05%3.93%3.93%2.17%0.00%0.00%0.00%0.00%
WST
West Pharmaceutical Services, Inc.
0.27%0.31%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%

Financials

WST vs. AMCR - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Amcor plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B6.00B20222023202420252026
844.90M
5.91B
(WST) Total Revenue
(AMCR) Total Revenue
Values in USD except per share items

WST vs. AMCR - Profitability Comparison

The chart below illustrates the profitability comparison between West Pharmaceutical Services, Inc. and Amcor plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%25.0%30.0%35.0%40.0%20222023202420252026
35.1%
20.1%
Portfolio components
WST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a gross profit of 296.40M and revenue of 844.90M. Therefore, the gross margin over that period was 35.1%.

AMCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amcor plc reported a gross profit of 1.19B and revenue of 5.91B. Therefore, the gross margin over that period was 20.1%.

WST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported an operating income of 177.10M and revenue of 844.90M, resulting in an operating margin of 21.0%.

AMCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amcor plc reported an operating income of 461.00M and revenue of 5.91B, resulting in an operating margin of 7.8%.

WST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a net income of 138.80M and revenue of 844.90M, resulting in a net margin of 16.4%.

AMCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amcor plc reported a net income of 278.00M and revenue of 5.91B, resulting in a net margin of 4.7%.


Frequently Asked Questions


WST and AMCR have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMCR has higher volatility (9.21%) compared to WST (7.76%). In terms of maximum drawdown, WST dropped -59.29% vs AMCR's -47.21%.

WST currently has the higher Sharpe Ratio (1.05 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WST and AMCR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer